Beijing Northland Biotech. Co., Ltd.   Report issue

For profit Phase 1 Phase 3
Founded: Beijing China (2004)
Status: No NME R&D (2004)

Organization Overview

First Clinical Trial
2012
NCT01548378
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Beijing Northland Biotech. Co., Ltd.